Challenges of microRNA-based biomarkers in clinical application for cardiovascular diseases.
作者信息
de Gonzalo-Calvo David, Pérez-Boza Jennifer, Curado Joao, Devaux Yvan
机构信息
Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, Lleida, Spain.
CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.
出版信息
Clin Transl Med. 2022 Feb;12(2):e585. doi: 10.1002/ctm2.585.
Abstract
摘要
相似文献
1
Challenges of microRNA-based biomarkers in clinical application for cardiovascular diseases.基于微小RNA的生物标志物在心血管疾病临床应用中的挑战
Clin Transl Med. 2022 Feb;12(2):e585. doi: 10.1002/ctm2.585.
2
Novel biomarkers in the prognosis, progression and treatment of cardiovascular disease: the role of microRNAs.心血管疾病预后、进展及治疗中的新型生物标志物：微小RNA的作用
Curr Top Med Chem. 2013;13(13):1491-2. doi: 10.2174/15680266113139990097.
3
Extracellular Vesicles in Cardiovascular Disease: Potential Applications in Diagnosis, Prognosis, and Epidemiology.细胞外囊泡在心血管疾病中的作用：在诊断、预后和流行病学中的潜在应用。
Circ Res. 2017 May 12;120(10):1649-1657. doi: 10.1161/CIRCRESAHA.117.310752.
4
The diagnostic and prognostic potential of plasma extracellular vesicles for cardiovascular disease.血浆细胞外囊泡在心血管疾病中的诊断和预后潜力。
Expert Rev Mol Diagn. 2015;15(12):1577-88. doi: 10.1586/14737159.2015.1109450. Epub 2015 Nov 4.
5
Recent progress toward the use of circulating microRNAs as clinical biomarkers.循环微RNA作为临床生物标志物应用的最新进展。
Arch Toxicol. 2016 Dec;90(12):2959-2978. doi: 10.1007/s00204-016-1828-2. Epub 2016 Sep 1.
6
miRNA Profiling of Extracellular Vesicles Reveals Biomarkers for Psoriasis.细胞外囊泡的微小RNA分析揭示了银屑病的生物标志物。
J Invest Dermatol. 2021 Jan;141(1):185-189.e4. doi: 10.1016/j.jid.2020.04.021. Epub 2020 May 21.
7
Extracellular vesicles in liver diseases.肝脏疾病中的细胞外囊泡。
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G194-G200. doi: 10.1152/ajpgi.00216.2016. Epub 2016 Dec 30.
8
MicroRNA-143/-145 in Cardiovascular Diseases.心血管疾病中的微小RNA - 143 / - 145
Biomed Res Int. 2015;2015:531740. doi: 10.1155/2015/531740. Epub 2015 Jun 28.
9
Detecting miRNA biomarkers from extracellular vesicles for cardiovascular disease with a microfluidic system.利用微流控系统从细胞外囊泡中检测心血管疾病的 miRNA 生物标志物。
Lab Chip. 2018 Sep 26;18(19):2917-2925. doi: 10.1039/c8lc00386f.
10
The biology of circulating microRNAs in cardiovascular disease.循环微小RNA在心血管疾病中的生物学特性
Eur J Clin Invest. 2015 Aug;45(8):860-74. doi: 10.1111/eci.12475.
引用本文的文献
1
From Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure.从利钠肽到微小RNA：心力衰竭中的多分析物液体活检前景
Biomolecules. 2025 Aug 19;15(8):1189. doi: 10.3390/biom15081189.
2
MicroRNAs as novel biomarkers for prenatal fetal congenital heart disease - systematic literature review.微小RNA作为产前胎儿先天性心脏病的新型生物标志物——系统文献综述
Front Genet. 2025 Jul 30;16:1628632. doi: 10.3389/fgene.2025.1628632. eCollection 2025.
3
Circulating levels of miR-20b-5p are associated with survival in cardiogenic shock.循环中miR-20b-5p的水平与心源性休克的生存率相关。
J Mol Cell Cardiol Plus. 2025 Jan 17;11:100284. doi: 10.1016/j.jmccpl.2025.100284. eCollection 2025 Mar.
4
Machine learning for catalysing the integration of noncoding RNA in research and clinical practice.机器学习在推动非编码 RNA 在研究和临床实践中的整合中的应用。
EBioMedicine. 2024 Aug;106:105247. doi: 10.1016/j.ebiom.2024.105247. Epub 2024 Jul 18.
5
MicroRNA as Sepsis Biomarkers: A Comprehensive Review.微小 RNA 作为脓毒症生物标志物的研究进展：一项全面综述。
Int J Mol Sci. 2024 Jun 12;25(12):6476. doi: 10.3390/ijms25126476.
6
MicroRNA Expression in Patients with Coronary Artery Disease and Hypertension-A Systematic Review.冠心病合并高血压患者的 microRNA 表达：系统综述。
Int J Mol Sci. 2024 Jun 11;25(12):6430. doi: 10.3390/ijms25126430.
7
miR-449a: A Promising Biomarker and Therapeutic Target in Cancer and Other Diseases.miR-449a：癌症和其他疾病中有前途的生物标志物和治疗靶点。
Cell Biochem Biophys. 2024 Sep;82(3):1629-1650. doi: 10.1007/s12013-024-01322-9. Epub 2024 May 29.
8
Analysis of IL-17A, IL-17F, and miR-146a-5p Prior to Transplantation and Their Role in Kidney Transplant Recipients.移植前白细胞介素-17A、白细胞介素-17F和微小RNA-146a-5p的分析及其在肾移植受者中的作用
J Clin Med. 2024 May 15;13(10):2920. doi: 10.3390/jcm13102920.
9
Non-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease.非编码RNA作为缺血性心脏病的治疗靶点和生物标志物
Nat Rev Cardiol. 2024 Aug;21(8):556-573. doi: 10.1038/s41569-024-01001-5. Epub 2024 Mar 18.
10
Improving the Performance of Selective Solid-State Nanopore Sensing Using a Polyhistidine-Tagged Monovalent Streptavidin.利用组氨酸标记的单价链霉亲和素提高选择性固态纳米孔传感性能。
ACS Sens. 2024 Mar 22;9(3):1602-1610. doi: 10.1021/acssensors.4c00200. Epub 2024 Mar 7.
本文引用的文献
1
Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points.外周血 microRNAs 与 COVID-19 患者：方法学考虑、技术挑战与实践要点。
RNA Biol. 2021 May;18(5):688-695. doi: 10.1080/15476286.2021.1885188. Epub 2021 Feb 15.
2
mir15a/mir16-1 cluster and its novel targeting molecules negatively regulate cardiac hypertrophy.mir15a/mir16 - 1簇及其新型靶向分子对心肌肥大起负向调节作用。
Clin Transl Med. 2020 Dec;10(8):e242. doi: 10.1002/ctm2.242.
3
Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids.利用机器学习建模和循环微小核糖核酸改善血液透析终末期肾病患者的心血管风险预测。
Theranostics. 2020 Jul 9;10(19):8665-8676. doi: 10.7150/thno.46123. eCollection 2020.
4
MicroRNA-331 and microRNA-151-3p as biomarkers in patients with ST-segment elevation myocardial infarction.微小 RNA-331 和微小 RNA-151-3p 作为 ST 段抬高型心肌梗死患者的生物标志物。
Sci Rep. 2020 Apr 3;10(1):5845. doi: 10.1038/s41598-020-62835-w.
5
Extracellular microRNAs in blood differentiate between ischaemic and haemorrhagic stroke subtypes.血液中的细胞外微小RNA可区分缺血性和出血性中风亚型。
J Extracell Vesicles. 2020 Jan 24;9(1):1713540. doi: 10.1080/20013078.2020.1713540. eCollection 2020.
6
A comparison of RNA extraction and sequencing protocols for detection of small RNAs in plasma.血浆中小 RNA 检测的 RNA 提取和测序方案比较。
BMC Genomics. 2019 Jun 3;20(1):446. doi: 10.1186/s12864-019-5826-7.
7
Circulating microRNAs in suspected stable coronary artery disease: A coronary computed tomography angiography study.疑似稳定型冠状动脉疾病患者的循环 microRNAs：冠状动脉 CT 血管造影研究。
J Intern Med. 2019 Sep;286(3):341-355. doi: 10.1111/joim.12921. Epub 2019 Jun 19.
8
Combining Circulating MicroRNA and NT-proBNP to Detect and Categorize Heart Failure Subtypes.联合循环 microRNA 和 NT-proBNP 检测和分类心力衰竭亚型。
J Am Coll Cardiol. 2019 Mar 26;73(11):1300-1313. doi: 10.1016/j.jacc.2018.11.060.
9
Large Differences in Small RNA Composition Between Human Biofluids.人体生物体液中小 RNA 组成的巨大差异。
Cell Rep. 2018 Oct 30;25(5):1346-1358. doi: 10.1016/j.celrep.2018.10.014.
10
Comprehensive multi-center assessment of small RNA-seq methods for quantitative miRNA profiling.综合多中心评估小 RNA-seq 方法用于定量 miRNA 分析。
Nat Biotechnol. 2018 Sep;36(8):746-757. doi: 10.1038/nbt.4183. Epub 2018 Jul 16.
Zotero 插件